FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3153291097> ?p ?o ?g. }

• W3153291097 endingPage "e25551" @default.
• W3153291097 startingPage "e25551" @default.
• W3153291097 abstract "The aim of the study was to evaluate the efficacy of nicorandil and alprostadil on myocardial protection in patients undergoing elective percutaneous coronary intervention (PCI).In this prospective, single-blinded, randomized controlled study, 90 consecutive patients scheduled for elective PCI for de novo coronary lesions were assigned to the nicorandil, alprostadil, and nitroglycerin groups in a 1:1:1 ratio. Drugs were administered intracoronary via a targeted perfusion microcatheter. The primary endpoint was the thrombolysis in myocardial infarction (TIMI) myocardial perfusion frame count (TMPFC). Additionally, the corrected TIMI frame count (cTFC), TIMI myocardial perfusion grade (TMPG), and incidence of periprocedural myocardial injury (PMI) were assessed.Both nicorandil and alprostadil were significantly effective in reducing TMPFC (114.6 ± 33.7 vs 93.4 ± 30.9, P = .016; 114.3 ± 34.3 vs 94.7 ± 33.3, P = .029, respectively). Similar findings were observed in the improvement of cTFC (20.3 ± 10.5 vs 13.5 ± 5.0, P = .003; 20.2 ± 7.4 vs 15.2 ± 5.2, P = .003, respectively) and percentage of TMPG 3 (100% vs 82.8%, P = .052; 83.3% vs 96.7%, P = .196, respectively); whereas, nitroglycerin produced a limited effect on TMPFC (114.4 ± 30.9 vs 112.1 ± 31.9, P = .739), cTFC (19.4 ± 7.2 vs 19.3 ± 7.2, P = .936), and percentage of TMPG 3 (86.7% vs 86.7%, P = 1.000). No significant difference was found in the incidence of PMI (16.7% vs 16.0% vs 27.6%, P = .537), though it was comparatively lower in the nicorandil and alprostadil groups. Furthermore, the intracoronary administration of nicorandil and alprostadil had a mild effect on blood pressure and heart rate.The intracoronary administration of nicorandil and alprostadil via a targeted perfusion microcatheter was more effective in improving myocardial perfusion in patients undergoing elective PCI than nitroglycerin." @default.
• W3153291097 created "2021-04-26" @default.
• W3153291097 creator A5013671823 @default.
• W3153291097 creator A5015779745 @default.
• W3153291097 creator A5022801684 @default.
• W3153291097 creator A5031044167 @default.
• W3153291097 creator A5054804924 @default.
• W3153291097 creator A5058706226 @default.
• W3153291097 creator A5059974206 @default.
• W3153291097 creator A5060229752 @default.
• W3153291097 creator A5061455357 @default.
• W3153291097 creator A5066702942 @default.
• W3153291097 creator A5067010958 @default.
• W3153291097 creator A5076163638 @default.
• W3153291097 creator A5078341118 @default.
• W3153291097 date "2021-04-16" @default.
• W3153291097 modified "2023-10-18" @default.
• W3153291097 title "Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention" @default.
• W3153291097 cites W1128023805 @default.
• W3153291097 cites W1609891060 @default.
• W3153291097 cites W1822602603 @default.
• W3153291097 cites W1850173473 @default.
• W3153291097 cites W1936833235 @default.
• W3153291097 cites W1964955756 @default.
• W3153291097 cites W1982177901 @default.
• W3153291097 cites W1982914035 @default.
• W3153291097 cites W1997821255 @default.
• W3153291097 cites W2005486302 @default.
• W3153291097 cites W2021926698 @default.
• W3153291097 cites W2023923511 @default.
• W3153291097 cites W2025068128 @default.
• W3153291097 cites W2030031420 @default.
• W3153291097 cites W2036833966 @default.
• W3153291097 cites W2037709494 @default.
• W3153291097 cites W2049083798 @default.
• W3153291097 cites W2078538563 @default.
• W3153291097 cites W2087165431 @default.
• W3153291097 cites W2100118923 @default.
• W3153291097 cites W2114560052 @default.
• W3153291097 cites W2121406973 @default.
• W3153291097 cites W2142935346 @default.
• W3153291097 cites W2153090042 @default.
• W3153291097 cites W2162700772 @default.
• W3153291097 cites W2170455508 @default.
• W3153291097 cites W2189063229 @default.
• W3153291097 cites W2601162416 @default.
• W3153291097 cites W2625184917 @default.
• W3153291097 cites W2741900278 @default.
• W3153291097 cites W2783303866 @default.
• W3153291097 cites W2790322840 @default.
• W3153291097 cites W2800638104 @default.
• W3153291097 cites W2800833236 @default.
• W3153291097 cites W2851638352 @default.
• W3153291097 cites W2909124687 @default.
• W3153291097 cites W2961188009 @default.
• W3153291097 cites W319829344 @default.
• W3153291097 cites W4230914943 @default.
• W3153291097 cites W4298051975 @default.
• W3153291097 cites W4361805466 @default.
• W3153291097 doi "https://doi.org/10.1097/md.0000000000025551" @default.
• W3153291097 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8052047" @default.
• W3153291097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33847683" @default.
• W3153291097 hasPublicationYear "2021" @default.
• W3153291097 type Work @default.
• W3153291097 sameAs 3153291097 @default.
• W3153291097 citedByCount "5" @default.
• W3153291097 countsByYear W31532910972021 @default.
• W3153291097 countsByYear W31532910972022 @default.
• W3153291097 countsByYear W31532910972023 @default.
• W3153291097 crossrefType "journal-article" @default.
• W3153291097 hasAuthorship W3153291097A5013671823 @default.
• W3153291097 hasAuthorship W3153291097A5015779745 @default.
• W3153291097 hasAuthorship W3153291097A5022801684 @default.
• W3153291097 hasAuthorship W3153291097A5031044167 @default.
• W3153291097 hasAuthorship W3153291097A5054804924 @default.
• W3153291097 hasAuthorship W3153291097A5058706226 @default.
• W3153291097 hasAuthorship W3153291097A5059974206 @default.
• W3153291097 hasAuthorship W3153291097A5060229752 @default.
• W3153291097 hasAuthorship W3153291097A5061455357 @default.
• W3153291097 hasAuthorship W3153291097A5066702942 @default.
• W3153291097 hasAuthorship W3153291097A5067010958 @default.
• W3153291097 hasAuthorship W3153291097A5076163638 @default.
• W3153291097 hasAuthorship W3153291097A5078341118 @default.
• W3153291097 hasBestOaLocation W31532910971 @default.
• W3153291097 hasConcept C126322002 @default.
• W3153291097 hasConcept C146957229 @default.
• W3153291097 hasConcept C164705383 @default.
• W3153291097 hasConcept C2777995511 @default.
• W3153291097 hasConcept C2778902376 @default.
• W3153291097 hasConcept C2779581417 @default.
• W3153291097 hasConcept C2780400711 @default.
• W3153291097 hasConcept C45393284 @default.
• W3153291097 hasConcept C500558357 @default.
• W3153291097 hasConcept C71924100 @default.
• W3153291097 hasConceptScore W3153291097C126322002 @default.
• W3153291097 hasConceptScore W3153291097C146957229 @default.
• W3153291097 hasConceptScore W3153291097C164705383 @default.
• W3153291097 hasConceptScore W3153291097C2777995511 @default.

• next